cancer diagnosis

"Midkine has very limited
expression in healthy adults, but is detectable in high quantities in the blood and
urine of patients with a wide variety of cancers. "

I think what we could be ultimately heading for here is routine blood testing for a wide variety of cancers doing for these cancers what the PSA test has done for prostate cancer detection. Hopefully more accurately and offering earlier detection.

Thats just some of the blue sky associated with this stock but even in the near future the current market cap is extremely low given what this company has achieved thus far.

We should have more long termers getting in now and we have a solid re-rating going on here I believe.

I am in top up mode.